Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Year: 2013
Type: article
Study design: Case Report
Abstract: Duration of Pneumocystis pneumonia (PCP) prophylaxis after allogeneic HSCT is not well defined. Guidelines recommend at least six months, and longer for patients on immunosuppression. We report six cases of PCP that happened late after allo-HSCT (median 36 months, range 19-80). All had received peripheral blood HSCT: three from matched sibling donors (MRD), and three from matched unrelated donors (MUD) (the latter with alemtuzumab conditioning). At the time of PCP, three patients (#3, #4, #5) were not on immunosuppression and had no active graft versus host disease (GVHD).
Institution: National Cancer Institute
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2153784341
